Novabay Pharmaceuticals Incの収益YQ/Q
Novabay Pharmaceuticals Incの収益YQ/Qは何ですか。
Novabay Pharmaceuticals Incの収益YQ/Qは-47.94%です。
収益YQ/Qの定義は何ですか。
四半期収益成長率、前年比は、前年同期の業績と比較して、売上高の増加率がパーセンテージとして表されています。
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
NYSEMKTのセクタHealth Careにおける収益YQ/Qの企業と比べるNovabay Pharmaceuticals Inc
Novabay Pharmaceuticals Incは何をしますか。
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Novabay Pharmaceuticals Incと類似の収益yq/q
- Future Supply Chain Solutionsの収益YQ/Qは-48.03%です。
- Grand Gulfの収益YQ/Qは-48.03%です。
- Organovo Incの収益YQ/Qは-48.00%です。
- Tata Motorsの収益YQ/Qは-47.97%です。
- Ganfeng Lithium Coの収益YQ/Qは-47.96%です。
- Kanoria Chemicals & Industriesの収益YQ/Qは-47.95%です。
- Novabay Pharmaceuticals Incの収益YQ/Qは-47.94%です。
- Satuの収益YQ/Qは-47.86%です。
- Eaton Vance Short Duration Diversified Income Fundの収益YQ/Qは-47.85%です。
- Manfield Chemicalの収益YQ/Qは-47.85%です。
- ShaMaran Petroleumの収益YQ/Qは-47.83%です。
- Fluenceの収益YQ/Qは-47.82%です。
- Nobleの収益YQ/Qは-47.76%です。